Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jespersen

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Journal of Medicine|January 1, 1988
Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or bothA Rasmussen, P T Hansen, J Lindholt, et al.
Thrombosis and Haemostasis|September 24, 1999
Longevity is independent of common variations in genes associated with cardiovascular riskE M Bladbjerg, K Andersen-Ranberg, M P de Maat, et al.
Thrombosis and Haemostasis|January 17, 2003
European Concerted Action on Anticoagulation (ECAA): International Normalized Ratio variability of CoaguChek and TAS point-of-care testing whole blood prothrombin time monitorsL Poller, M Keown, N Chauhan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Human Reproduction (Oxford, England)|February 16, 2006
Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosisMoniek P M de Maat, E-M Bladbjerg, C Kluft, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal womenJ S Madsen, S R Kristensen, J Gram, et al.
Lancet (London, England)|February 18, 1995
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitusB Myrup, P M Hansen, T Jensen, et al.
Ugeskrift for Laeger|January 28, 1991
[Standardized prothrombin time determinations and optimal anticoagulant therapy]J Jespersen, M S Hansen, J Dyerberg, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 25, 2007
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosisJ J Sidelmann, J A Sjøland, J Gram, et al.
Medical Mycology|February 6, 2009
Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigenNgolela Esther Babady, Jean E Bestrom, Deborah J Jespersen, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Journal of Medicine|January 1, 1988
Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or bothA Rasmussen, P T Hansen, J Lindholt, et al.
Thrombosis and Haemostasis|September 24, 1999
Longevity is independent of common variations in genes associated with cardiovascular riskE M Bladbjerg, K Andersen-Ranberg, M P de Maat, et al.
Thrombosis and Haemostasis|January 17, 2003
European Concerted Action on Anticoagulation (ECAA): International Normalized Ratio variability of CoaguChek and TAS point-of-care testing whole blood prothrombin time monitorsL Poller, M Keown, N Chauhan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Human Reproduction (Oxford, England)|February 16, 2006
Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosisMoniek P M de Maat, E-M Bladbjerg, C Kluft, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal womenJ S Madsen, S R Kristensen, J Gram, et al.
Lancet (London, England)|February 18, 1995
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitusB Myrup, P M Hansen, T Jensen, et al.
Ugeskrift for Laeger|January 28, 1991
[Standardized prothrombin time determinations and optimal anticoagulant therapy]J Jespersen, M S Hansen, J Dyerberg, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 25, 2007
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosisJ J Sidelmann, J A Sjøland, J Gram, et al.
Medical Mycology|February 6, 2009
Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigenNgolela Esther Babady, Jean E Bestrom, Deborah J Jespersen, et al.
Pageof 21